CJC/IPA No DAC Blend
Combines CJC-1295 No DAC with Ipamorelin to target two complementary signaling pathways. The No DAC variant maintains a shorter duration of action enabling pulsatile GH dynamics.
Wholesale Pricing
Available Doses & Tiered Pricing
CJC/IPA No DAC Blend 5/5mg
Save 38%- 50 vials$32.00 / vial
- 100 vials$28.00 / vial
- 250 vials$24.00 / vial
- 500 vials★ Best Value$20.00 / vial
Overview
Combines CJC-1295 No DAC with Ipamorelin to target two complementary signaling pathways. The No DAC variant maintains a shorter duration of action enabling pulsatile GH dynamics.
History
Designed for amplification of physiologic GH pulse patterns rather than sustained elevation.
Key Areas of Research
- Pulsatile GH dynamics
- IGF-1 pathway stimulation
- Circadian rhythm modulation
References
- Alba M. et al. (2005). Growth Horm IGF Res 15(5):333–339.
- Svensson J. et al. (1998). Ipamorelin selective GH release. JCEM 83(9):3094–3101.
Research Use Only
All products are intended solely for laboratory research purposes and are not for human or animal consumption. Must be handled by qualified professionals.
Related Compounds
Growth Hormone
Tesamorelin
Tesamorelin is a synthetic GHRH analog studied for somatotroph axis modulation and downstream signaling cascades in laboratory models.
View details →Growth Hormone
Sermorelin
Sermorelin is a synthetic peptide analog of GHRH (1-29) studied for modulation of somatotroph axis signaling and associated downstream cascades.
View details →Growth Hormone
Ipamorelin
Ipamorelin is a synthetic pentapeptide and selective secretagogue-type agonist with minimal off-target pathway interference, used to study endocrine signaling and somatotroph axis modulation.
View details →